ArticleInternational journal of clinical oncology2026

RNF125 mediates the anti-breast cancer activity of betulinic acid through ubiquitin-dependent degradation of MYH9.

Peng Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.